Thrivane Health LLC operates the Thrivane platform and does not practice medicine. Medical services are provided by independent, licensed healthcare providers. All treatment is subject to medical evaluation, eligibility, availability and applicable law. Prescriptions are issued only when a licensed provider determines treatment is appropriate.
Where compounded medications are prescribed, they are prepared by licensed pharmacies and are not FDA-approved or evaluated for safety, effectiveness or quality. Product images are stylized renders. Lifestyle images are illustrative and do not depict patients. Prices shown are proposed launch pricing.
*Average weight loss of about 34 lbs (semaglutide, STEP 1, 68 weeks) and about 48 lbs (tirzepatide highest dose, SURMOUNT-1, 72 weeks) in trials of the FDA-approved versions with diet and exercise, calculated from each trial’s average starting weight. Compounded versions were not studied in these trials. Individual results vary.
© 2026 Thrivane Health LLC